ACM
NVCR icon

AlphaCrest Capital Management’s NovoCure NVCR Stock Holding History

AlphaCrest Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,718
Closed -$738K – 776
2022
Q3 		$738K Sell
9,718
-16,762
-63% -$1.31M 0.05% 780
2022
Q2 		$1.84M Buy
26,480
+19,485
+279% +$1.47M 0.09% 364
2022
Q1 		$580K Sell
6,995
-18,907
-73% -$1.39M 0.03% 828
2021
Q4 		$1.95M Buy
25,902
+15,302
+144% +$1.54M 0.07% 447
2021
Q3 		$1.23M Buy
10,600
+7,288
+220% +$1.1M 0.06% 518
2021
Q2 		$735K Sell
3,312
-4,477
-57% -$871K 0.03% 799
2021
Q1 		$1.03M Buy
+7,789
New +$1.23M 0.06% 488
2020
Q4 		– Sell
-2,300
Closed -$256K – 1227
2020
Q3 		$256K Sell
2,300
-3,000
-57% -$240K 0.03% 946
2020
Q2 		$314K Sell
5,300
-5,000
-49% -$329K 0.05% 608
2020
Q1 		$694K Buy
10,300
+5,900
+134% +$466K 0.08% 426
2019
Q4 		$371K Sell
4,400
-12,900
-75% -$1.04M 0.03% 954
2019
Q3 		$1.29M Buy
17,300
+6,100
+54% +$488K 0.08% 426
2019
Q2 		$708K Buy
+11,200
New +$568K 0.06% 555

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's NVCR Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of NovoCure (NVCR) in Q4 2022, closing a stake of 9,718 shares — an estimated $738K sold.

AlphaCrest Capital Management first reported a position in NVCR in Q2 2019 and held it in 13 quarters. The position peaked at $1.95M in Q4 2021. 305 funds tracked by Wall St. Rank hold NVCR as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining NovoCure position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 9,718 NovoCure shares in Q4 2022, an estimated $738K.
  • AlphaCrest Capital Management first reported a position in NovoCure in Q2 2019 and held it in 13 quarters.
  • AlphaCrest Capital Management's NovoCure position peaked at $1.95M in Q4 2021.
  • 305 funds tracked by Wall St. Rank held NovoCure as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.